Pain management in cancer patients with bone metastases remains a challenge

By Yau V.   Chow E.   Davis L.   Holden L.   Schueller T.   Danjoux C.  

Journal of Pain and Symptom Management, Vol. 27, Iss. 1, 2004-01 ,pp. : 1-3

Elsevier

Access to resources Recommend Favorite

Targeting castration-resistant prostate cancer with monoclonal antibodies and constructs

By Slovin Susan F  

Immunotherapy, Vol. 5, Iss. 12, 2013-12 ,pp. : 1347-1355

Future Medicine

Access to resources Recommend Favorite

Targeting ErbB3: the New RTK(id) on the Prostate Cancer Block

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 11, Iss. 2, 2011-06 ,pp. : 131-149

Bentham Science Publishers

Access to resources Recommend Favorite

Screening of Antihypertensive Drugs for Osteoclastic Acid Secretion and Bone Resorption by Acridine Orange

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 3, 2012-07 ,pp. : 161-167

Bentham Science Publishers

Access to resources Recommend Favorite

High CD10 expression in lymph node metastases from surgically treated prostate cancer independently predicts early death

By Fleischmann Achim   Rocha Carla   Saxer-Sekulic Nikolina   Zlobec Inti   Sauter Guido   Thalmann George  

Virchows Archiv, Vol. 458, Iss. 6, 2011-06 ,pp. : 741-748

Springer Publishing Company

Access to resources Recommend Favorite